Natixis Advisors LLC lowered its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 32.1% during ...
Ionis Pharmaceuticals has entered a licence agreement with Sobi in which the latter obtains exclusive rights to commercialise ...
In return, Ionis will receive an undisclosed upfront payment from Sobi. It is also eligible to receive milestone payments and a tiered royalty on the drug's future sales.
Envestnet Portfolio Solutions Inc. trimmed its holdings in Applied Industrial Technologies, Inc. (NYSE:AIT – Free Report) by ...
RTX’s Raytheon business has carried out the first launch of a new Coyote LE SR uncrewed aerial system (UAS) from a helicopter ...
With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are ...